Evaluation and Management of Enlarged Prostate in Young Men

Introduction to Diagnostic Approach

The American Urological Association recommends measuring serum testosterone levels immediately in a young patient with a markedly enlarged prostate and elevated PSA, as abnormally high testosterone or exogenous testosterone use could explain both the prostatic enlargement and elevated PSA 1, 2
The American College of Physicians suggests measuring hematocrit or hemoglobin as essential baseline values that can be affected by hormonal abnormalities and are required before any testosterone-related intervention 1, 2
The Endocrine Society recommends measuring luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to help differentiate primary versus secondary hypogonadism if testosterone is low, or identify autonomous testosterone production if levels are elevated 1
The American Association of Clinical Endocrinologists suggests measuring estradiol levels, as they can be elevated in certain endocrine disorders and may contribute to prostatic growth 1

A normal prostate volume at age 25 is approximately 20-25 grams, and a 68-gram prostate is profoundly abnormal, warranting immediate urology referral 3
The American Urological Association recommends excluding active prostatitis, as PSA can be dramatically elevated during prostatic inflammation, before proceeding with prostate biopsy 4
The National Comprehensive Cancer Network suggests confirming the patient is not on any 5-alpha reductase inhibitors (finasteride, dutasteride), as these reduce PSA by approximately 50% within 6 months, and any PSA elevation while on these medications is highly concerning for malignancy 4
The European Association of Urology recommends verifying no recent ejaculation, vigorous physical activity, or prostate manipulation within 48-72 hours before PSA measurement, as these can transiently elevate PSA 4

The American Cancer Society recommends immediate urology referral for a PSA >4.0 ng/mL, as this is an established threshold requiring urologic evaluation 1, 2, 5
The American Urological Association suggests that an abnormal digital rectal examination, such as a prostate this enlarged (68g versus normal ~20-25g at age 25), is definitively abnormal and warrants biopsy regardless of PSA value 1, 2, 5
The National Institute for Health and Care Excellence recommends calculating PSA density (PSA ÷ prostate volume in mL), as this is one of the strongest predictors for clinically significant prostate cancer and will help risk-stratify the patient 4

The New England Journal of Medicine explicitly states that all men presenting for possible testosterone therapy who have abnormal PSA or abnormal digital rectal examination must first undergo prostate biopsy, and the American Urological Association recommends holding all hormonal interventions until malignancy is excluded 1, 2, 4